ANXA1 and inflammatory bowel disease: Elevated serum levels of ANXA1-containing EVs were also observed when comparing healthy controls and patients with active inflammation due to IBD, indicating that ANXA1-containing EVs are systemically distributed in response to the inflammatory process.